Laura Bobolts, PharmD, BCOP, discusses key cost drivers impacting treatments for upper GI and esophageal cancers. Laura Bobolts, PharmD, BCOP: There are 3 main cost drivers I typically think about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback